NovoNorm

NovoNorm

repaglinide

Manufacturer:

Novo Nordisk

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Repaglinide
Indications/Uses
Type 2 DM whose hyperglycaemia is not controlled satisfactorily by diet, wt reduction & exercise. In combination w/ metformin in type 2 DM unsatisfactorily controlled on metformin alone. Adjunct to diet & exercise.
Dosage/Direction for Use
Initially 0.5 mg, titrated on wkly or bi-wkly basis. Patient transferred from another oral hypoglycemic agent Initially 1 mg. Max single dose: 4 mg. Max total daily dose: 16 mg.
Administration
Should be taken with food: Usually taken w/in 15 min of the meal but time may vary from immediately preceding the meal to as long as 30 min before the meal. Patients who skip a meal (or add an extra meal) should be instructed to skip (or add) a dose for that meal.
Contraindications
Hypersensitivity. Type 1 DM, C-peptide -ve. Diabetic ketoacidosis w/ or w/o coma. Severe hepatic dysfunction. Concomitant use of gemfibrozil.
Special Precautions
Discontinue use if patient is exposed to stress eg, fever, trauma, infection or surgery. Increased risk of hypoglycaemia w/ combination treatment. Increased incidence of acute coronary syndrome (eg, MI). Debilitated or malnourished patients. Renal & hepatic insufficiency. May affect the ability to drive or operate machinery in case of hypoglycaemia. Pregnancy & lactation.
Adverse Reactions
Hypoglycaemia, abdominal pain, diarrhoea; CV disease, allergic reactions, refraction disorder, vomiting & constipation, abnormal hepatic function, increased liver enzymes.
Drug Interactions
May enhance &/or prolong hypoglycaemic effect w/ gemfibrozil, trimethoprim, rifampicin, ketoconazole, itraconazole, clarithromycin, ciclosporin, deferasirox, clopidogrel, other antidiabetic agents, MAOIs, nonselective β-blockers, ACE inhibitors, salicylates, NSAIDs, octreotide, alcohol & anabolic steroids. Reduce hypoglycemic effect w/ OCs, rifampicin, barbiturates, carbamazepine, thiazides, corticosteroids, danazol, thyroid hormones & sympathomimetics.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BX02 - repaglinide ; Belongs to the class of other blood glucose lowering drugs excluding insulins. Used in the treatment of diabetes.
Presentation/Packing
Form
NovoNorm tab 0.5 mg
Packing/Price
90's
Form
NovoNorm tab 1 mg
Packing/Price
90's
Form
NovoNorm tab 2 mg
Packing/Price
90's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in